Information Update - Update: Pharmascience Inc. recalls 30 lots of 150 mg over-the-counter ranitidine in blister packs

OTTAWA, ON, March 11, 2022 /CNW/ - Pharmascience Inc. is recalling 30 lots of over-the-counter ranitidine drugs (150 mg tablets) packaged in blister packs, after tests found NDMA, a nitrosamine impurity, above the acceptable level in some lots. NDMA is classified as a probable human carcinogen, which means long-term exposure to levels above what is considered safe could increase the risk of cancer. The products are sold under various private labels. Please refer to the Affected Products table for detailed information on the recalled lots.

Health Canada maintains a list of ranitidine drugs affected by this issue. Please see the full advisory for more information, including what consumers should do.

Affected Products

Product  Name	DIN	Strength	Lot
ATOMA maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744F
ATOMA maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632058H
Compliments maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043B
Compliments maximum strength acid reducer without prescription cool mint (24 tablets)	02293471	150 mg	629973A
CO-OP Care+ maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744C
Health One maximum strength acid reducer without prescription (32 tablets)	02293471	150 mg	629744J
Health One maximum strength acid reducer without prescription (32 tablets)	02293471	150 mg	632043H
Life Brand maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744H
Life Brand maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632058I
Life Brand maximum strength acid reducer without prescription cool mint (48 tablets)	02293471	150 mg	629974B
Life Brand maximum strength acid reducer without prescription cool mint (24 tablets)	02293471	150 mg	629974A
Option+ maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744G
Option+ maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043D
Option+ maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043E
Option+ maximum strength acid reducer without prescription (8 tablets)	02293471	150 mg	632058A
Option+ maximum strength acid reducer without prescription cool mint (24 tablets)	02293471	150 mg	629973B
Option+ maximum strength acid reducer without prescription cool mint (24 tablets)	02293471	150 mg	631893C
PERSONNELLE maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744E
PERSONNELLE maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043A
PERSONNELLE maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043F
PERSONNELLE maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632058J
PERSONNELLE maximum strength acid reducer without prescription (8 tablets)	02293471	150 mg	629744B
PERSONNELLE maximum strength acid reducer without prescription (8 tablets)	02293471	150 mg	632058B
PERSONNELLE maximum strength acid reducer without prescription cool mint (24 tablets)	02293471	150 mg	629973C
PERSONNELLE maximum strength acid reducer without prescription cool mint (48 tablets)	02293471	150 mg	629973D
PHARMASAVE maximum strength acid reducer without prescription (8 tablets)	02293471	150 mg	629744A
Rexall maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	629744I
Rexall maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632043G
Rexall maximum strength acid reducer without prescription (24 tablets)	02293471	150 mg	632058G
Rexall maximum strength acid reducer without prescription (8 tablets)	02293471	150 mg	632058D

Également disponible en français

SOURCE Health Canada

Media Inquiries: Également disponible en français, Health Canada, [phone], [email protected]; Public Inquiries: [phone], 1-866 225-0709, [email protected]